Canagliflozin
Created:
7/13/20
Submitted:
3/6/23
Published:
3/6/23
24812758-bas-color-print_NIH3DAtoms shown as ball-and-stick with standard colors.
Select an image below to view
Category
Description
Canagliflozin is a C-glycosyl compound that is used (in its hemihydrate form) for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2. It has a role as a hypoglycemic agent and a sodium-glucose transport protein subtype 2 inhibitor. It is a C-glycosyl compound, a member of thiophenes and an organofluorine compound.
